The U.S. Patent and Trademark Office Patent Trial and Appeal Board today denied a rehearing request after a loss in a spat between Johnson & Johnson (NYSE:JNJ) and Covidien, now owned by Medtronic (NYSE:MDT) . The case, over surgical stapler patents owned by Johnson & Johnson and contested by Medtronic, was originally filed in 2013. The decision today was […]
Medtronic
FDA warns Medtronic’s Tyrx on anti-bacterial envelopes
The FDA sent a warning letter earlier this month to Medtronic (NYSE:MDT) subsidiary Tyrx over problems with its process validation and quality systems. The Tyrx envelopes are designed to elute a pair of anti-microbial drugs, minocycline and rifampin, for 7 days before dissolving over a period of roughly 9 weeks. They’re cleared for use with pacemakers, implantable cardioverter-defibrillators, cardiac […]
FDA OKs epilepsy trial for MDT’s Visualase MRI-guided laser
Medtronic (NYSE:MDT) said today that the FDA granted an investigational device exemption for a clinical trial of its Visualase ablation device in treating temporal lobe epilepsy. Fridley, Minn.-based Medtronic put $105 million on the table for Houston-based Visualase back in 2014, including $70 million in up-front cash and another $35 million in milestones. Medtronic had […]
Medtronic inks partnership deal with self-management program dev Canary Health
Medtronic (NYSE:MDT) is partnering with digital health self-management program developer Canary Health to resell and distribute its full suite of chronic disease self-management programs, including its Diabetes Prevention Program. Through the partnership, the 2 companies will also develop additional solutions that operate around Medtronic’s devices, services and infrastructure as well as Canary Health’s platform of behavior […]
Medtronic touts ‘closed-loop’ insulin management system | American Diabetes Assn. 2016 Scientific Sessions
Medtronic touts ‘closed-loop’ insulin management system In its latest step on the quest to create an artificial pancreas, Medtronic (NYSE:MDT) said a pivotal trial showed that its hybrid “closed-loop” insulin management system proved safe and effective. The HCL system is designed to automatically control blood glucose levels with minimal input or supervision from patients or […]
Study backs laser prostate ablation with Medtronic’s Artemis
Laser ablation may be a feasible and safe treatment option for men with intermediate risk prostate cancer, according to a new study published in the Journal of Urology. The treatment operates using magnetic resonance imaging to guide a laser fiber into a cancerous tumor in the prostate to destroy the tissue with extreme heat. The study […]
Medtronic touts shorter stays, less retreats with cryoablation for treating paroxysmal AF
Medtronic (NYSE:MDT) today touted data from its Fire and Ice clinical trial indicating lower rates of repeat procedures and shorter hospital stays for patients with paroxysmal atrial fibrillation treated with its Arctic Front cryoballoon when compared to those treated with radiofrequency ablation catheters. Data from the secondary analysis of the study comparing the company’s Arctic Front […]
Tax court hands Medtronic a win in $1.4B IRS case
A federal judge yesterday found for Medtronic (NYSE:MDT) in its lawsuit against the IRS over a $1.36 billion tax bill. The dispute involves “transfer pricing” among the company’s various units during the tax years 2005 and 2006. The tax bureau claimed Medtronic owed income tax of $548.2 million for 2005 and $810.3 million for 2006; the […]
Ascensia Diabetes reups development deal with Medtronic
Asensia Diabetes Care said today it renewed a diabetes management development partnership with Medtronic (NYSE:MDT), through which Ascensia will retain exclusive rights to co-develop and supply Contour Next Link and Contour Plus Link blood glucose monitors. The Contour blood glucose meters are wirelessly compatible and designed to communicate with Medtronic’s integrated insulin pump and continuous […]
Study: Lower major complication risk with Medtronic’s Micra compared to conventional pacers
Medtronic (NYSE:MDT) today released new results from a clinical trial of its leadless Micra transcatheter pacing system, touting significantly reduced major complication risks compared to conventional pacing systems. The Micra transcatheter pacing system, which at 1/10th the size of a conventional pacemaker is roughly the size of a large vitamin, is designed to be implanted via […]
Medtronic launches Valiant Evo TAA device trial
Medtronic (NYSE:MDT) said today it enrolled the 1st patient in a trial of its Valiant Evo thoracic stent graft system designed for the minimally invasive repair of descending thoracic aortic aneurysms. The 1st procedure in the trial was performed recently at the Univeristy of Texas Health Science Center at Houston by principal investigator Ali Azizzadeh, […]